ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,177
Screening encounters
4,975
Diagnostic referrals
948
Outstanding pathways
327

Screening pathway

  1. Screening4,975Encounters
  2. Positive finding1,720Documented findings
  3. Referral948Diagnostic referrals
  4. Follow-up1,134Diagnostic visits
  5. Outcome621Resolved pathways

Stage totals use different units. Pending pathways: 327. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1013 · EXP-1013Synthetic · Site D

Full participant history through 2027-01-21, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · LSIL · Adequate
  3. · Diagnostic referral · EXP-1013-T-R
  4. · Contact attempt · Unsuccessful
  5. · Diagnostic booking · Initial booking
  6. · Contact attempt · Reached
  7. · Barrier documented · Contact difficulty
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · High-grade lesion
  11. · Follow-up disposition · Resolved · EXP-1013-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4177 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1778 · Expanded synthetic participant 1778Site B — Peri-Urban Access Programme
EXP-1779 · Expanded synthetic participant 1779Site B — Peri-Urban Access Programme
EXP-1780 · Expanded synthetic participant 1780Site C — Rural Outreach Programme
EXP-1781 · Expanded synthetic participant 1781Site B — Peri-Urban Access Programme
EXP-1785 · Expanded synthetic participant 1785Site D — Community Engagement Programme
EXP-1786 · Expanded synthetic participant 1786Site D — Community Engagement Programme
EXP-1789 · Expanded synthetic participant 1789Site E — Resource-Constrained Navigation Programme
EXP-1791 · Expanded synthetic participant 1791Site B — Peri-Urban Access Programme
EXP-1792 · Expanded synthetic participant 1792Site B — Peri-Urban Access Programme
EXP-1793 · Expanded synthetic participant 1793Site B — Peri-Urban Access Programme
EXP-1796 · Expanded synthetic participant 1796Site C — Rural Outreach Programme
EXP-1797 · Expanded synthetic participant 1797Site E — Resource-Constrained Navigation Programme
EXP-1798 · Expanded synthetic participant 1798Site A — Urban Referral Hub
EXP-1799 · Expanded synthetic participant 1799Site C — Rural Outreach Programme
EXP-1800 · Expanded synthetic participant 1800Site B — Peri-Urban Access Programme
EXP-1801 · Expanded synthetic participant 1801Site A — Urban Referral Hub
EXP-1802 · Expanded synthetic participant 1802Site E — Resource-Constrained Navigation Programme
EXP-1804 · Expanded synthetic participant 1804Site A — Urban Referral Hub
EXP-1806 · Expanded synthetic participant 1806Site B — Peri-Urban Access Programme
EXP-1808 · Expanded synthetic participant 1808Site E — Resource-Constrained Navigation Programme
EXP-1809 · Expanded synthetic participant 1809Site B — Peri-Urban Access Programme
EXP-1810 · Expanded synthetic participant 1810Site E — Resource-Constrained Navigation Programme
EXP-1811 · Expanded synthetic participant 1811Site E — Resource-Constrained Navigation Programme
EXP-1812 · Expanded synthetic participant 1812Site A — Urban Referral Hub
EXP-1815 · Expanded synthetic participant 1815Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1889
HPV DNA
2389
Cytology
697

Navigation activity

Barrier documented
853
Contact attempt
1382
Navigation intervention
373
Diagnostic booking
1180
Diagnostic visit
1134

Documented barriers

Contact difficulty
275
Transport difficulty
280
Appointment coordination
298

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.